Page last updated: 2024-08-23

cromolyn sodium and Carcinoma, Pancreatic Ductal

cromolyn sodium has been researched along with Carcinoma, Pancreatic Ductal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arumugam, T; Bornmann, WG; Logsdon, CD; Maxwell, DS; Pal, A; Peng, Z; Ramachandran, V; Sun, D	1

Other Studies

1 other study(ies) available for cromolyn sodium and Carcinoma, Pancreatic Ductal

Article	Year
Designing and developing S100P inhibitor 5-methyl cromolyn for pancreatic cancer therapy. Molecular cancer therapeutics, 2013, Volume: 12, Issue:5 Topics: Animals; Antineoplastic Agents; Apoptosis; Calcium-Binding Proteins; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Cromolyn Sodium; Drug Design; Drug Evaluation, Preclinical; Humans; Male; Mice; Mice, Nude; Neoplasm Proteins; NF-kappa B; Pancreatic Neoplasms; Protein Binding; Receptor for Advanced Glycation End Products; Tumor Burden; Xenograft Model Antitumor Assays	2013

Article

Year

Designing and developing S100P inhibitor 5-methyl cromolyn for pancreatic cancer therapy.

Molecular cancer therapeutics, 2013, Volume: 12, Issue:5

Topics: Animals; Antineoplastic Agents; Apoptosis; Calcium-Binding Proteins; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Cromolyn Sodium; Drug Design; Drug Evaluation, Preclinical; Humans; Male; Mice; Mice, Nude; Neoplasm Proteins; NF-kappa B; Pancreatic Neoplasms; Protein Binding; Receptor for Advanced Glycation End Products; Tumor Burden; Xenograft Model Antitumor Assays

2013